News & Updates

Safety data from the phase III ADAURA study support osimertinib as an effective adjuvant therapy for resectable, stage IB–IIIA EGFR-mutated non–small-cell lung cancer (NSCLC), says an expert.

Pregnant women with high levels of thyroid stimulating hormone (TSH), which indicate hypothyroidism, are at risk of adverse pregnancy outcomes, a study has found.

Treatment with inclisiran in real-world settings appears to produce significant reductions in low-density lipoprotein cholesterol (LDL-C) at 2 months with good tolerability, with results consistent with that reported in previous trials, according to a study.

Performing physical activity in the morning, between 8:00 and 11:00 am, appears to be associated with a lower risk of cardiovascular disease (CVD), particularly coronary artery disease (CAD) and stroke, in adults than engaging in physical activity at other times of the day, a recent study has shown. 

Continuous total haemoglobin (SpHb) monitoring with a noninvasive device facilitates effective blood management during a major surgery, helping to avoid unnecessary or a delay in transfusions, according to a study.